In Phase 2 clinical trials, the safety profile was broadly consistent with other incretin-based therapies, with gastrointestinal side effects being the most commonly reported
This helps keep your weight stable and ensures long-term success without needing to keep increasing your dosage
Special considerations in older adults Ruchi Gaba, MD, an associate professor of endocrinology at Baylor College of Medicine in Houston, says that she thinks about multiple factors before prescribing GLP-1s for her patients 65 and older
Step four: Add water to the peptide vial
What you do to lose the weight, its short term
Now production cannot keep up with demand for this instant blockbuster peptide drug, also marketed for weightloss as Wegovy, and the similar GLP-1 drug developed by Lilly, tirzepatide (Zepbound or Mounjaro)